218 related articles for article (PubMed ID: 19138309)
1. Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report.
Wild D; Eremenco S; Mear I; Martin M; Houchin C; Gawlicki M; Hareendran A; Wiklund I; Chong LY; von Maltzahn R; Cohen L; Molsen E
Value Health; 2009 Jun; 12(4):430-40. PubMed ID: 19138309
[TBL] [Abstract][Full Text] [Related]
2. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
[TBL] [Abstract][Full Text] [Related]
3. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
[TBL] [Abstract][Full Text] [Related]
4. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.
Matza LS; Patrick DL; Riley AW; Alexander JJ; Rajmil L; Pleil AM; Bullinger M
Value Health; 2013 Jun; 16(4):461-79. PubMed ID: 23796280
[TBL] [Abstract][Full Text] [Related]
5. Translation and psychometric properties of the Persian version of self-management of type 1 diabetes for adolescents.
Karahroudy FA; Shahboulaghi FM; Hosseini MA; Rassouli M; Biglarian A
J Pediatr Endocrinol Metab; 2016 Jul; 29(7):761-7. PubMed ID: 27124671
[TBL] [Abstract][Full Text] [Related]
6. Family pediatrics: report of the Task Force on the Family.
Schor EL;
Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
[TBL] [Abstract][Full Text] [Related]
7. Validation of electronic systems to collect patient-reported outcome (PRO) data-recommendations for clinical trial teams: report of the ISPOR ePRO systems validation good research practices task force.
Zbrozek A; Hebert J; Gogates G; Thorell R; Dell C; Molsen E; Craig G; Grice K; Kern S; Hines S
Value Health; 2013 Jun; 16(4):480-9. PubMed ID: 23796281
[TBL] [Abstract][Full Text] [Related]
8. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
Jansen JP; Fleurence R; Devine B; Itzler R; Barrett A; Hawkins N; Lee K; Boersma C; Annemans L; Cappelleri JC
Value Health; 2011 Jun; 14(4):417-28. PubMed ID: 21669366
[TBL] [Abstract][Full Text] [Related]
9. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
Hoaglin DC; Hawkins N; Jansen JP; Scott DA; Itzler R; Cappelleri JC; Boersma C; Thompson D; Larholt KM; Diaz M; Barrett A
Value Health; 2011 Jun; 14(4):429-37. PubMed ID: 21669367
[TBL] [Abstract][Full Text] [Related]
10. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I.
Berger ML; Mamdani M; Atkins D; Johnson ML
Value Health; 2009; 12(8):1044-52. PubMed ID: 19793072
[TBL] [Abstract][Full Text] [Related]
11. PRO data collection in clinical trials using mixed modes: report of the ISPOR PRO mixed modes good research practices task force.
Eremenco S; Coons SJ; Paty J; Coyne K; Bennett AV; McEntegart D;
Value Health; 2014 Jul; 17(5):501-16. PubMed ID: 25128043
[TBL] [Abstract][Full Text] [Related]
12. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
13. A pragmatic approach ensuring accuracy in language translation in tuberculosis research.
Rennie TW; Engova D; Bates I
Res Social Adm Pharm; 2008 Dec; 4(4):417-21. PubMed ID: 19064247
[TBL] [Abstract][Full Text] [Related]
14. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force.
Cleeland CS; Sloan JA; Cella D; Chen C; Dueck AC; Janjan NA; Liepa AM; Mallick R; O'Mara A; Pearson JD; Torigoe Y; Wang XS; Williams LA; Woodruff JF;
Cancer; 2013 Jan; 119(2):411-20. PubMed ID: 22930243
[TBL] [Abstract][Full Text] [Related]
16. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
17. Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.
Garrison LP; Neumann PJ; Erickson P; Marshall D; Mullins CD
Value Health; 2007; 10(5):326-35. PubMed ID: 17888097
[TBL] [Abstract][Full Text] [Related]
18. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
Cox E; Martin BC; Van Staa T; Garbe E; Siebert U; Johnson ML
Value Health; 2009; 12(8):1053-61. PubMed ID: 19744292
[TBL] [Abstract][Full Text] [Related]
19. A methodology for successfully producing global translations of patient reported outcome measures for use in multiple countries.
Two R; Verjee-Lorenz A; Clayson D; Dalal M; Grotzinger K; Younossi ZM
Value Health; 2010; 13(1):128-31. PubMed ID: 19695006
[TBL] [Abstract][Full Text] [Related]
20. Linguistic validation of the DN4 for use in international studies.
Van Seventer R; Vos C; Meerding W; Mear I; Le Gal M; Bouhassira D; Huygen FJ
Eur J Pain; 2010 Jan; 14(1):58-63. PubMed ID: 19282208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
